Measuring energy requirements during pulmonary exacerbations of cystic fibrosis using indirect calorimetry

Document Type

Journal Article

Publication Title

Nutrition

Volume

112

PubMed ID

37263161

Publisher

Elsevier

School

School of Medical and Health Sciences

RAS ID

58013

Comments

McCafferty, K., Henderson, J., Mulrennan, S., Jamieson, J., Properzi, C., & Tai, A. (2023). Measuring energy requirements during pulmonary exacerbations of cystic fibrosis using indirect calorimetry. Nutrition, 112, article 112073. https://doi.org/10.1016/j.nut.2023.112073

Abstract

Objective: The energy demands of individuals with cystic fibrosis (CF) vary depending on pancreatic function, body composition, lung function, and clinical status. In clinical practice, predictive equations are used to determine energy requirements yet do not reliably account for these factors. Research regarding energy requirements during CF pulmonary exacerbation (CFPEx) and clinical stability is conflicting. The aim of this study was to investigate potential within-individual changes in measured resting energy expenditure (mREE) using indirect calorimetry (IC) at the commencement and completion of intravenous antibiotic treatment (IVABx) for CFPEx and during clinical stability. Secondary aims were to investigate potential differences between predicted resting energy expenditure (pREE) using Schofield equation and correlations between clinical factors with mREE. Methods: Body composition using bioimpedance analysis and mREE were conducted at three time points: commencement of IVABx; completion of IVABx; and clinically stable period thereafter. Results: Twenty-eight adults with CF completed at least one valid IC measurement. No significant within-person changes in mREE and body composition parameters were observed across time points. The mREE was positively correlated with fat-free mass (kg; r = 0.6; P = 0.008). The mREE was significantly higher than pREE at all time points with the mREE/pREE ratio elevated at time point 1:118% ± 19.5%; time point 2: 112% ± 13.2%; and time point 3: 122 ± 14.3%. Conclusion: The mREE remained stable during CFPEx and clinical stability. The pREE underestimated mREE and application of injury factor adjustment of 110% to 130% could potentially account for this discrepancy. The potential role of IC and body composition in individualizing CF nutritional assessment and prescription requires further exploration.

DOI

10.1016/j.nut.2023.112073

Access Rights

subscription content

Link to Full Text

Share

 
COinS